Attention & Memory Impairments in Menopausal Women

NCT01324024 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Symptomatic Menopause
Cognitive Impairments

Interventions

DRUG: Lisdexamfetamine
DRUG: Placebo

Sponsor

University of Pennsylvania

Collaborators

[object Object]